Related references
Note: Only part of the references are listed.Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer?s disease
Licong Yang et al.
CARBOHYDRATE POLYMERS (2023)
Recent progress in nanotechnology-based drug carriers for resveratrol delivery
Chunhong Li et al.
DRUG DELIVERY (2023)
Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
Cyrus Jalili et al.
IET NANOBIOTECHNOLOGY (2023)
Potential Treatment Options for Neuroblastoma with Polyphenols through Anti-Proliferative and Apoptotic Mechanisms
Aisha Kafoud et al.
BIOMOLECULES (2023)
Targeting Mitochondrial Oxidative Phosphorylation in Glioblastoma Therapy
Zhihao Wu et al.
NEUROMOLECULAR MEDICINE (2022)
Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy
Qi Zhan et al.
NEURO-ONCOLOGY (2022)
Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway (vol 9, pg 1401, 2015)
Yingshan Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)
Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics
Laura Guarnaccia et al.
CANCERS (2022)
Lipid-Coated Nanocrystals as a Tool for Improving the Antioxidant Activity of Resveratrol
Monica Argenziano et al.
ANTIOXIDANTS (2022)
Enhanced circulation longevity and pharmacodynamics of metformin from surface-modified nanostructured lipid carriers based on solidified reverse micellar solutions
Franklin Chimaobi Kenechukwu et al.
HELIYON (2022)
Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer
Bhurichaya Innets et al.
MOLECULES (2022)
Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study
Hossein Ebrahimi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)
Hurdling over the blood-brain barrier with exosome technology
James Felker et al.
NEURO-ONCOLOGY (2022)
Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies
Makoto Ohno et al.
CANCERS (2022)
Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin
Shao-Wei Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma
Kelly J. McKelvey et al.
FRONTIERS IN ONCOLOGY (2021)
Brain and other central nervous system tumor statistics, 2021
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Evaluation of Blood-Brain Barrier Permeability of Polyphenols, Anthocyanins, and Their Metabolites
Rena Shimazu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
High glucose: an emerging association between diabetes mellitus and cancer progression
Suangson Supabphol et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2021)
A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma
Keren Porper et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
The potential of metformin as an antineoplastic in brain tumors: A systematic review
Famila Takhwifa et al.
HELIYON (2021)
Pak2 inhibition promotes resveratrol-mediated glioblastoma A172 cell apoptosis via modulating the AMPK-YAP signaling pathway
Jin Xing et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Metformin as Potential Therapy for High-Grade Glioma
Marek Mazurek et al.
CANCERS (2020)
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Zhilin Zou et al.
CELL AND BIOSCIENCE (2020)
Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine
Lenka Koklesova et al.
EPMA JOURNAL (2020)
Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism
Marek Samec et al.
EPMA JOURNAL (2020)
Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression
Chenglai Xia et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options
Xiaowei Wu et al.
CELL DEATH & DISEASE (2020)
Resveratrol-loaded folate targeted lipoprotein-mimetic nanoparticles with improved cytotoxicity, antioxidant activity and pharmacokinetic profile
Neelam Poonia et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Preparation, preliminary pharmacokinetic and brain targeting study of metformin encapsulated W/O/W composite submicron emulsions promoted by borneol
Lufeng Hong et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Metformin Treatment Suppresses Melanoma Cell Growth and Motility through Modulation of microRNA Expression
Hui-Wen Tseng et al.
CANCERS (2019)
Resveratrol and siRNA in combination reduces Hsp27 expression and induces caspase-3 activity in human glioblastoma cells
Evren Onay Ucar et al.
CELL STRESS & CHAPERONES (2019)
The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression
Marek Samec et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
High Glucose Promotes Human Glioblastoma Cell Growth by Increasing the Expression and Function of Chemoattractant and Growth Factor Receptors
Zhiyao Bao et al.
TRANSLATIONAL ONCOLOGY (2019)
Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
Christina Piperi et al.
CELLS (2019)
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma
Stefania Maraka et al.
CANCER (2019)
The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysis
Victor M. Lu et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells
Marwa Al Hassan et al.
ANALYTICAL CELLULAR PATHOLOGY (2018)
High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy
Jung Eun Lee et al.
CANCER RESEARCH AND TREATMENT (2018)
Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK
Jing Wang et al.
ONCOTARGETS AND THERAPY (2018)
Resveratrol as an anti-cancer agent: A review
Abdur Rauf et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration
Paul A. Clark et al.
JOURNAL OF NEUROSURGERY (2017)
Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
Ke Chen et al.
MOLECULAR CANCER (2017)
The blood-brain barrier in Alzheimer's disease
Elena Zenaro et al.
NEUROBIOLOGY OF DISEASE (2017)
Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
Silvia Valtorta et al.
ONCOTARGET (2017)
Association Between Perioperative Hyperglycemia and Survival in Patients With Glioblastoma
Katherine Hagan et al.
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY (2017)
The influence of hyperglycemia during radiotherapy on survival in patients with primary glioblastoma
Sebastian Adeberg et al.
ACTA ONCOLOGICA (2016)
Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of Vitamin E TPGS coated trans resveratrol liposomes
Mahalingam Rajamanickam Vijayakumar et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation
Xin-pin Wu et al.
ACTA PHARMACOLOGICA SINICA (2015)
Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways
Guangxiu Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
Minh Thi Tieu et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo
Long Wang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway
Yuming Jiao et al.
NUTRIENTS (2015)
Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
Zhiyun Yu et al.
ONCOTARGET (2015)
Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response
Julie Sesen et al.
PLOS ONE (2015)
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Jigisha P. Thakkar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
Krzysztof Łabuzek et al.
Pharmacological Reports (2014)
Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme
Arnulf Mayer et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Resveratrol Enhances the Antitumor Effects of Temozolomide in Glioblastoma via ROS-dependent AMPK-TSC-mTOR Signaling Pathway
Yuan Yuan et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
Atsushi Sato et al.
STEM CELLS TRANSLATIONAL MEDICINE (2012)
Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases-Safety, Pharmacokinetics, and Pharmacodynamics
Lynne M. Howells et al.
CANCER PREVENTION RESEARCH (2011)
Clinical Pharmacokinetics of Metformin
Garry G. Graham et al.
CLINICAL PHARMACOKINETICS (2011)
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Maria M. Mihaylova et al.
NATURE CELL BIOLOGY (2011)
Autophagy Interplay with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Resveratrol in Glioma Cells
Eduardo C. Filippi-Chiela et al.
PLOS ONE (2011)
Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
Ketan R. Patel et al.
CANCER RESEARCH (2010)
Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas
Kaisorn L. Chaichana et al.
NEUROLOGICAL RESEARCH (2010)
Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance
Kimmo J. Hatanpaa et al.
NEOPLASIA (2010)
The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells
Jun Li et al.
BMC CANCER (2009)
Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma
Rachel L. Derr et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Resveratrol inhibits glucose metabolism in human ovarian cancer cells
Angela Kueck et al.
GYNECOLOGIC ONCOLOGY (2007)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis
A. Isakovic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
High absorption but very low bioavailability of oral resveratrol in humans
T Walle et al.
DRUG METABOLISM AND DISPOSITION (2004)
Insulin: A novel factor in carcinogenesis
K Gupta et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
